Accenture plc (ACN), the world's largest professional-services and IT-consulting firm by headcount, has staged a powerful rebound in the second half of 2026. After fears that generative AI could disrupt its consulting business sent the shares tumbling earlier in the year, strong fourth-quarter results and a long-awaited investor day have lifted the stock to roughly $237. The question now is whether the rally has further to run — and specifically whether ACN can reach $278, currently the highest price target on Wall Street.
Accenture is in an unusual position: its shares have rallied above the average analyst price target. Across roughly 27 current estimates, the mean 12-month price target is near $225, with a range from about $163 to $278 — slightly below the October 19 closing price of $236.93. Because that average no longer implies meaningful upside, this article relies on a fallback objective rather than a fabricated consensus.
The $278 figure comes from identifiable public discussion: UBS reiterated a Buy rating and raised its target to $278 (from $275) ahead of the investor day, a level it described as the highest on Wall Street. That single, named target — not an average — is the reference point here. For context, other recent targets include Goldman Sachs and Argus at $260, Evercore ISI at $250, Mizuho at $241, and RBC Capital at $240 on the bullish side, while more cautious firms sit lower: Morgan Stanley at $195, J.P. Morgan at $200, Citigroup at $190, and Deutsche Bank at $175.
Sentiment is best described as constructive but divided. Roughly four in ten covering analysts rate the stock a Buy or equivalent, with the remainder at Hold and no Sell ratings. The wide spread between the low and high targets itself signals how differently analysts weigh Accenture's AI opportunity against its pricing and demand risks.
As of the October 19 close, ACN traded at $236.93, with a market capitalization of roughly $145–148 billion and a trailing P/E (price-to-earnings ratio) near 17.5. Reaching $278 would require a gain of about 17%, a substantial move from current levels, though well below the rebound the stock has already staged off its 2026 lows.
The path toward $278 would most likely depend on Accenture converting its AI momentum into durable, higher-margin revenue. Fourth-quarter revenue rose 7% in local currency, with record new bookings of about $22.2 billion that included 37 client deals exceeding $100 million each. Management guided fiscal 2027 to 3%–6% local-currency growth and 10–30 basis points of adjusted operating-margin expansion. To justify a higher multiple, investors would need to see bookings hold up and AI-related work keep scaling without eroding pricing.
ACN's recovery has been sharp: the stock trades roughly 25% above its 50-day moving average near $190 and its 200-day average near $193, reflecting strong momentum but also a meaningful gap from longer-term trendlines. The 52-week range runs from $118.15 to $291.09. On the upside, the prior high near $291 stands as the most significant overhead reference, well above the $278 objective. On the downside, the $225–$230 area — where many analyst targets cluster — represents a natural support zone, followed by the moving-average band near $190–$193. A failure to hold above $225 would likely signal that post-earnings momentum has faded.
Analyst price targets typically reflect a roughly 12-month research horizon, and the $278 UBS figure should be read the same way, even though individual analysts differ in their assumptions about AI adoption and pricing. The next key catalyst is the fiscal first-quarter earnings report, scheduled for mid-December 2026, followed by any revisions to bookings, guidance, and margins. Investors should also watch analyst target changes, AI-booking disclosures, the health of the U.S. federal business, and any evidence that fixed-price contracts are pressuring margins. Economic data and interest-rate decisions remain relevant to enterprise IT spending broadly.
For traders monitoring names like ACN, AI Daily Buy/Sell Signals from Tickeron provide a data-driven complement to fundamental research. The tool uses artificial intelligence to continuously scan thousands of stocks and ETFs and generate Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. Traders can use these signals to surface new opportunities, track existing positions, and spot shifting trends more efficiently than manual chart review alone. As Accenture's post-earnings momentum evolves, pairing analyst context with real-time AI signals can help investors stay ahead of the trend.
Whether ACN can reach $278 depends less on a single quarter and more on whether Accenture can keep converting AI demand into profitable, recurring revenue while defending pricing. The $278 target — UBS's Street-high objective — is not a consensus figure; the average analyst target of roughly $225 actually sits below the current price, a clear sign that Wall Street is divided on how much upside remains. The strongest supports are accelerating AI bookings, record new business, and credible long-term growth targets, while the principal obstacles are valuation, pricing pressure, federal-business softness, and a technically overbought chart. A move to $278 would require about 17% further appreciation, a substantial but not unprecedented step given the stock's recent trajectory. Investors should focus on the December earnings report, guidance, and any margin or pricing signals before drawing conclusions.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, ACN has been closely correlated with GLOB. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if ACN jumps, then GLOB could also see price increases.
| Ticker / NAME | Correlation To ACN | 1D Price Change % | ||
|---|---|---|---|---|
| ACN | 100% | +0.92% | ||
| GLOB - ACN | 75% Closely correlated | +3.76% | ||
| EPAM - ACN | 73% Closely correlated | +2.59% | ||
| EXLS - ACN | 72% Closely correlated | +2.77% | ||
| G - ACN | 72% Closely correlated | +2.71% | ||
| GIB - ACN | 71% Closely correlated | +4.18% | ||
More | ||||
| Ticker / NAME | Correlation To ACN | 1D Price Change % |
|---|---|---|
| ACN | 100% | +0.92% |
| ACN (9 stocks) | 91% Closely correlated | +3.17% |
| Technology Services (395 stocks) | 13% Poorly correlated | +1.66% |